Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
T Cells
71%
Epstein-Barr Virus
59%
Cytotoxic T Lymphocytes
33%
Chimeric Antigen Receptor T Cells (CAR-T)
32%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
26%
Adoptive Immunotherapy
21%
Graft-versus-host Disease (GvHD)
21%
Virus-specific T Cells
20%
Adoptive Cell Therapy
18%
Lymphoma
18%
Virus-specific
17%
Hematopoietic Stem Cell Transplantation
17%
Tumor
16%
Cytotoxic T Cells
16%
Cytomegalovirus
15%
Adoptive Transfer
15%
Viral Infection
15%
Bone Marrow Transplantation
15%
Post-transplant Lymphoproliferative Disorder
14%
Virus
14%
Marrow
13%
Allogeneic Bone Marrow Transplantation
13%
Malignancy
12%
Interleukin-2
12%
Marrow Transplantation
12%
Tumor Antigen
12%
Lymphoproliferative Disorders
12%
Specific T Cells
12%
Adenovirus
12%
Genetic Modification
12%
Tumor Cells
11%
Unrelated Donor
10%
Hematological Malignancies
10%
Gene Transfer
9%
Antitumor Activity
9%
Virus-specific Cytotoxic T Lymphocytes
9%
Donor-derived
8%
CD19
8%
Stem Cell Transplantation
8%
Hodgkin Disease
8%
Tumor Necrosis Factor-α
8%
Clinical Response
8%
High Risk
8%
Leukemia
7%
Cell Therapy
7%
Allogeneic
7%
Epstein-Barr Virus Infections
7%
Acute Myeloid Leukemia
7%
T Cell Depletion
7%
Peripheral Blood
7%
Medicine and Dentistry
T Cell
77%
Epstein Barr Virus
51%
Cytotoxic T-Cell
36%
Cell Therapy
22%
Diseases
21%
Hematopoietic Stem Cell Transplantation
21%
Cancer
20%
Virus
18%
Immunotherapy
17%
Infusion
16%
Hematopoietic Cell
15%
Chimeric Antigen Receptor T-Cell
14%
Chimeric Antigen Receptor
14%
Adoptive Immunotherapy
13%
T Lymphocyte
13%
Virus Infection
12%
Lymphoproliferative Disease
12%
Pediatrics
12%
Stem Cell Therapy
11%
Hodgkin's Lymphoma
11%
B Cell
10%
Cytomegalovirus
10%
Neoplasm
10%
Bone Marrow Transplantation
9%
Hematologic Malignancy
8%
Tumor Antigen
8%
Leukemia
8%
Graft Versus Host Reaction
8%
Tumor
7%
Antigen Specificity
6%
Adenoviridae
6%
Epstein-Barr Virus Infection
6%
Allogenic Bone Marrow Transplantation
6%
Tumor Cell
6%
Adoptive Transfer
6%
Clinical Trial
6%
Allogeneic Hematopoietic Stem Cell Transplantation
5%
Lymphocyte
5%
Posttransplant Lymphoproliferative Disease
5%
Acute Lymphoblastic Leukemia
5%
Interleukin 2
5%
Stem Cell
5%
Cytokine
5%
Infection
5%
Acute Myeloid Leukemia
5%
Malignant Neoplasm
5%
Pediatrics Patient
5%
Non-Hodgkin Lymphoma
5%
Immunology and Microbiology
T Cell
100%
Epstein Barr Virus
63%
Cytotoxic T Cell
44%
Virus
27%
Immunotherapy
24%
Hematopoietic Stem Cell Transplantation
22%
Viral Disease
16%
Graft-Versus-Host Disease
16%
Chimeric Antigen Receptor
15%
Infection
14%
Bone Marrow Transplantation
14%
Adoptive Immunotherapy
14%
Hematopoietic Cell
14%
Stem Cell Transplantation
13%
Cytomegalovirus
13%
Adenoviridae
13%
B Cell
11%
Interleukin 2
11%
Cytokine
10%
Chimeric Antigen Receptor T-Cell
10%
T Cell Receptor
9%
Tumor Antigen
9%
CD19
8%
Antineoplastic Activity
8%
Myeloid
8%
Monoclonal Antibody
7%
Lymphoproliferative Disorders
7%
Lymphocyte
7%
Allogeneic Hematopoietic Stem Cell Transplantation
7%
Conditioning
6%
Tumor Cell
6%
Alemtuzumab
5%
Antigen Specificity
5%
Stem Cell
5%
Epitope
5%
In Vitro
5%
Stem Cell Transplant
5%
Caspase
5%
Peptides
5%